根据欧盟委员会第396/2005号法规第6章， ISK Biosciences Europe N.V.提交了该修订申请。根据消费者暴露评估，欧洲食品安全局得出结论，美国授权的氟啶虫酰胺使用量不会导致消费者急性或慢性接触超过毒理学参考值，因此不太可能对消费者健康构成风险。

 

　　部分原文报道如下：

 

　　In accordance with Article 6 of Regulation （EC ） No 396/2005, the applicant ISK Biosciences Europe N.V. submitted a request to the competent national authority in Finland to set an import tolerance for the active substance flonicamid in various crops and products of animal origin on the basis of the authorised use of flonicamid in the USA . The data submitted in support of the request were found to be sufficient to derive maximum residue level （MRL ） proposals for all crops under assessment. based on the results of the feeding studies and the updated animal burden calculations, no need for new MRL proposals on products of animal origin was identified. Adequate analytical methods for enforcement are available to control the residues of flonicamid in plant and animal matrices. EFSA updated the most recent consumer risk assessment for flonicamid and concluded that the authorised USA uses of flonicamid will not result in acute or chronic consumer exposure exceeding the toxicological reference values and, therefore, is unlikely to pose a risk to consumers' health.

 

　　本文由食品伙伴网食品资讯中心编辑，供网友参考，欢迎转载，转载请注明出处！有任何疑问，请联系news@www.sqrdapp.com。